Business

Announcement on Voluntary Disclosure of the Wholly-owned Subsidiary’s Intraocular Crosslinked Sodium Hyaluronate Gel Product Obtaining the Medical Device Registration Certificate

Announcement on Voluntary Disclosure of the Wholly-owned Subsidiary’s Intraocular Crosslinked Sodium Hyaluronate Gel Product Obtaining the Medical Device Registration Certificate

articleShanghai Haohai Biological Technology Co., Ltd. Class AMarch 16, 20265/news/announcement-on-voluntary-disclosure-of-the-wholly-owned-subsidiarys-intraocular-crosslinked-sodium-hyaluronate-gel-product-obtaining-the-medical-device-registration-certificate
Announcement on Voluntary Disclosure of the Wholly-owned Subsidiary’s Intraocular Crosslinked Sodium Hyaluronate Gel Product Obtaining the Medical Device Registration Certificate

About this update from Shanghai Haohai Biological Technology Co., Ltd. Class A

Announcement on Voluntary Disclosure of the Wholly-owned Subsidiary’s Intraocular Crosslinked Sodium Hyaluronate Gel Product Obtaining the Medical Device Registration Certificate The abstract is for reference only. Please refer to the full text of the announcement on the very day. Link of Full Text for Reference: View Attachment

View stock analysis, news, and events for Shanghai Haohai Biological Technology Co., Ltd. Class A